FDAnews
www.fdanews.com/articles/157330-idri-and-zydus-sign-agreement-for-development-of-idri-s-vaccine-candidate-for-visceral-leishmaniasis

IDRI and Zydus Sign Agreement for Development of IDRI's Vaccine Candidate for Visceral Leishmaniasis

July 25, 2013
IDRI and Zydus signed a deal wherein the two will jointly develop a vaccine for visceral leishmaniasis, a disease which is transmitted via the bites of sand flies.
Eurekalert